{{Rsnum
|rsid=642698
|Gene=ME2
|Chromosome=18
|position=50896615
|Orientation=minus
|GMAF=0.3118
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=ME2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 36.6 | 50.9 | 12.5
| HCB | 41.6 | 42.3 | 16.1
| JPT | 36.3 | 41.6 | 22.1
| YRI | 74.1 | 24.5 | 1.4
| ASW | 56.1 | 38.6 | 5.3
| CHB | 41.6 | 42.3 | 16.1
| CHD | 45.0 | 45.0 | 10.1
| GIH | 60.4 | 34.7 | 5.0
| LWK | 59.1 | 38.2 | 2.7
| MEX | 56.9 | 37.9 | 5.2
| MKK | 67.9 | 27.6 | 4.5
| TSI | 37.3 | 49.0 | 13.7
| HapMapRevision=28
}}

[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1196416] May Underlie Susceptibility to Adolescent-Onset Idiopathic Generalized [[Epilepsy]]

{{omim
|id=154270
|desc=MALIC ENZYME 2; ME2
|rsnum=642698
}}

{{omim
|id=154270
|rsnum=642698
|variant=0001
}}

{{PMID Auto
|PMID=15532013
|Title=Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}